Biogen (BIIB) Divestments (2009 - 2025)

Biogen's Divestments history runs 7 years deep, the most recent figure standing at $56.7 million for Q4 2025.

• In Q4 2025, Divestments rose 121.63% year-over-year to $56.7 million; the TTM figure through Dec 2025 stood at -$205.4 million (up 77.93% YoY), while the FY2025 annual figure was $56.7 million, down 60.82% from the prior year.
• Divestments was $56.7 million for Q4 2025 at Biogen, up from -$262.1 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $990.3 million in Q2 2022 to a low of -$990.3 million in Q4 2022.
• Historically, Divestments has averaged -$86.7 million across 5 years, with a median of $28.1 million in 2021.
• Biggest YoY gain for Divestments was 3624.2% in 2022; the steepest drop was 1614.22% in 2022.
• A 5-year view of Divestments shows it stood at $65.4 million in 2021, then sank by 1614.22% to -$990.3 million in 2022, then soared by 32.5% to -$668.5 million in 2023, then soared by 60.79% to -$262.1 million in 2024, then jumped by 121.63% to $56.7 million in 2025.
• The last three Divestments figures came in at $56.7 million (Q4 2025), -$262.1 million (Q4 2024), and -$668.5 million (Q4 2023), per Business Quant data.